Medication-assisted Treatment Research with Criminal Justice Populations: Challenges of Implementation

Behavioral Sciences and the Law

Volumn 29, Issue 6, 2011, Pages 829-845

  Gordon, Michael S ^a,b   Kinlock, Timothy W ^c   Miller, Patrice M ^d  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b STEVENSON UNIVERSITY   (United States)

^c UNIVERSITY OF BALTIMORE   (United States)

^d Army Substance Abuse Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NALTREXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ADDICTION; ARTICLE; ETHICS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PERSUASIVE COMMUNICATION; PILOT STUDY; PRISONER; UNITED STATES;

ANALGESICS, OPIOID; BUPRENORPHINE; COERCION; FEMALE; HUMAN EXPERIMENTATION; HUMANS; MALE; METHADONE; NALTREXONE; NARCOTIC ANTAGONISTS; PILOT PROJECTS; PRISONERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 81355161052     PISSN: 07353936     EISSN: 10990798     Source Type: Journal    
DOI: 10.1002/bsl.1015     Document Type: Article

References (55)

1. Albizu-Garcia, C. A., Correa, G. C., Hernandez Viver, A. D., Kinlock, T. W., Gordon, M. S., Avila, C. A., Reyes, C. I., & Schwartz, R. P. (2007). Feasibility of initiating treatment with buprenorphine-naloxone in a state prison for opiate dependent inmates nearing release. American Journal on Addictions, 1(3), 126-132.
2. Amass, L., Kamien, J. B., & Mikulich, S. K. (2000). Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet. Drug and Alcohol Dependence, 58(1-2), 143-152.
3. Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Oepsell, T. D. (2007). Release from prison - a high risk of death for former inmates. New England Journal of Medicine, 356, 157-165.
4. Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009). Treating drug abuse and addiction in the criminal justice system: Improving public health and safety. Journal of the American Medical Association, 301(2), 183-190.
5. Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H., Kampman, K., Dackis, C., & O'Brien, C. P. (2006). Injectable, sustained release naltrexone for the treatment of opioid dependence: A randomized, placebo-controlled trial. Archives of General Psychiatry, 63, 210-218.
6. Coviello, D. M., Cornish, J. W., Lynch, K. G., Boney, T., Clark, C., Lee, J. D., Friedmann, P. D., Nunes, E. V., Kinlock, T. W., Gordon, M. S., Schwartz, R. P., & O'Brien, C. P. (in press). A multi-site pilot study of depot naltrexone treatment for opioid-dependent offenders. Substance Use.
7. Dolan, K. A., Shearer, J., White, B., & Wodak, A. (2003). A randomized controlled trial of methadone maintenance treatment in NSW prisons. Technical report No. 155. Sydney: National Drug and Alcohol Research Centre.
8. Dolan, K. A., Shearer, J., White, B., Zhou, J., Kaldor, J., & Wodak, A. D. (2005). Four-year follow-up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration and hepatitis C infection. Addiction, 100, 820-828.
9. Dolan, K., Khoei, E. M., Brentari, C., & Stevens, A. (2007). Prisons and drugs: A global review of incarceration, drug use, and drug services. (Report 12). The Beckley Foundation Drug Policy Programme.
10. Dole, V., Robinson, J., Orraga, J., Towns, E., Searcy, P., & Caine, E. (1969). Methadone treatment of randomly selected criminal addicts. New England Journal of Medicine, 280, 1372-1375.
11. Farrell, M., & Marsden, J. (2008). Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction, 103, 251-255.
12. Farrington, D. P. (1999). Predictors, causes, and correlates of male youth violence. In Tonry M., & Moore M. H. (Eds.), Youth violence [Crime and justice: A review of research] (vol 24, pp. 421-475). Chicago: University of Chicago Press.
13. Fazel, S., Bains, P., Doll, H. (2006). Substance abuse and dependence in prisoners: a systematic review. Addiction, 101(2), 181-191.
14. Field, G. (1998). Continuity of treatment for substance abuse disorders from institution to community. Rockville, MD: Center for Substance Abuse Treatment, Treatment Improvement Protocol (TIP) Series 30, DHHS Publication No. (SMA), 98-3245.
15. Gordon, M. S., Kinlock, T. W., Schwartz, R. P., & O'Grady, K. E. (2008). A randomized clinical trial of methadone maintenance for prisoners: Findings at 6-months post-release. Addiction, 103, 1333-1342.
16. Gostin, L. O., Vanchieri, C., & Pope, A. (Eds.) (2007). Ethical considerations for research involving prisoners. Washington: National Academies Press.
17. Hornblum, A. M. (1998). Acres of skin: Human experiments at Holmesburg prison. New York: Routledge.
18. Hough M. (2002). Drug user treatment within a criminal justice context. Substance Use & Misuse, 37(8-10), 985-996.
19. Inciardi, J. A. (2008). The war on drugs III. Boston, MA: Allyn & Bacon.
20. Kanato, M. (2008). Drug use and health among prison inmates. Current Opinion in Psychiatry, 21, 252-254.
21. Kinlock, T. W., Battjes, R. J., & Schwartz, R. P. (2002). A novel opioid maintenance program for prisoners: preliminary findings. J Subst Abuse Treat, 22, 141-147.
22. Kinlock, T. W., & Gordon, M. S. (2006). Substance abuse treatment: New research. In Bennett L. A. (Ed.), New topics in substance abuse treatment (pp. 73-111). New York: Nova Science Publishers.
23. Kinlock, T.W., Gordon, M.S., Schwartz, R.P., O'Grady, K., Fitzgerald, T., & Wilson, M. (2007). A Randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release. Drug and Alcohol Dependence, 91, 220-227
24. Kinlock, T. W., Gordon, M. S., Schwartz, R. P., & O'Grady, E. (2008). A Study of Methadone Maintenance for Male Prisoners: Three-Month Post-Release Outcomes. Criminal justice and Behavior, 35 (1), 34-47.
25. Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Fitzgerald, T. T., & O'Grady, K. E. (2009). Methadone maintenance for prisoners: Results at twelve-months post-release. Journal of Substance Abuse Treatment, 37, 277-285.
26. Kinlock, T. W., Gordon, M. S., Schwartz, R. P. (2011). Incarcerated populations. In Ruiz P. & Strain E. (Eds.), Lowinson & Ruiz's Substance Abuse: A Comprehensive Textbook 5th ed. (pp. 881-891). Baltimore: Lippincott Williams & Wilkins.
27. Kinlock, T. W., O'Grady, K. E., & Hanlon, T. E. (2003). Prediction of the criminal activity of incarcerated drug-abusing offenders. Journal of Drug Issues, 33, 897-920.
28. Kinlock, T. W., Schwartz, R. P., & Gordon, M. S. (2005). The significance of interagency collaboration in developing opioid agonist programs for prisoners. Corrections Compendium, 30(3), 6-9, 28-30.
29. Kleber, H. D. (2008). Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. JAMA, 300(19), 2303-2305.
30. Krinsky, C., Lathrop, S., Brown, P., Nolte, K. (2009). Drugs, detention, and death: A study of the mortality of recently released prisoners. American Journal of Forensic Medicine and Pathology, 30(1), 6-9.
31. Krupitsky, E. M., & Blokhina, E. A. (2010). Long-acting depot formulations of naltrexone for heroin dependence: A review. Current Opinion in Psychiatry, 23(3), 210-214
32. Levasseur, L., Marzo, J. N., Ross, N., & Blatier, C. (2002). Frequency of re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis. Ann Med Interne (Paris), 153(3 Suppl), 1S14-1S19.
33. Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009). Buprenorphine and methadone maintenance in jail and post release: A randomized clinical trial. Drug and Alcohol Dependence, 99, 222-230.
34. Magura, S., Rosenblum, A., Lewis, C., & Joseph, H. (1993). The effectiveness of in-jail methadone maintenance. Journal of Drug Issues, 23, 75-99.
35. Merrall, E. L., Kariminia, A., Binswanger, I. A., Hobbs, M. S., Farrell, M., Marsden, J., Hutchinson, S. J., Bird, S. M. (2010). Meta-analysis of drug-related deaths soon after release from prison. Addiction, 105(9), 1545-1554.
36. Metz, V., Matzenauer, C., Kammerer, K., Winklbaur, B., Ebner, N., Radler, D., & Fischer, G. (2010). Evaluation of opioid-dependent prisoners in oral opioid maintenance therapy. Heroin Addiction and Related Clinical Problems, 12, 5-16.
37. Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. (2006). Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Systematic Reviews 2006(Issue 1. Art. No.: CD001333. DOI: 10.1002/14561858.CD001333.pub.2).
38. Mitford, J. (1974). Kind and Usual Punishment. New York: Vintage.
39. Montoya, I. D., Gorelick, D. A., Preston, K. A., Schroeder, J. R., Umbricht, A., Cheskin, L. J., Lange, W. R., Contoreggi, C., Johnson, R. E., & Fudala, P. J. (2004). Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clinical Pharmacology and Therapeutics, 7, 34-48.
40. Mumola, C. J. & Karberg, J. C. (2006). Drug use and dependence, state and federal prisoners, 2004. Washington, DC: U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
41. Nemes, S., Wish, E., Wraight, B., & Messina, N. (2003). Correlates of treatment follow-up difficulty. Substance Use & Misuse, 37, 19-45.
42. O'Brien, C., & Cornish, J. (2006). Naltrexone for probationers and parolee. Journal of Substance Abuse Treatment, 31(2), 107-111
43. Pelissier, B., & Jones, N. (2005). Treatment needs of substance-abusing women. Crime and Delinquency, 51, 343-372.
44. Pettinati H. M., Volpicelli J. R., Pierce, J. D., Jr., O'Brien C. P. (2000). Improving naltrexone response: An intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. Journal of Addictive Diseases, 19(1), 71-83.
45. Prendergast, M., & Wexler, H. (2004). Correctional substance-abuse treatment programs in California: A historical perspective. Prison Journal, 84(1), 8-35.
46. Schmalleger, F. (2010). Criminal Justice Today 10th ed. Upper Saddle River, NJ: Pearson/Prentice-Hall.
47. Schwartz, R. P., Mitchell, S. G., Gordon, M. S., & Kinlock, T. W. (in press). Pharmacotherapy. In Leukefeld C., & Gregrich J. (Eds.), Handbook on Evidence Based Substance Abuse Treatment Practice in Criminal Justice Settings. Spring Street, New York, NY 10013, USA: Springer Publishing.
48. Smith-Rohrberg, D., Bruce, R. D., & Altice, F. L. (2004). Research note-review of corrections-based therapy for opiate-dependent patients: implications for buprenorphine treatment among correctional populations. Journal of Drug Issues, 34, 451-480.
49. Stewart, L. M., Henderson, C. J., Hobbs, M. S., Ridout, S. C., & Knuiman, W. W. (2004). Risk of death in prisoners after release from jail. Australian and New Zealand Journal of Public Health, 28, 32-36.
50. Stojkovic, S., & Lovell, R. (1997). Corrections: An introduction. Cincinnati: Anderson.
51. Strang, J., Gossop, M., Heuston, J., Green, J., Whiteley, C., & Maden, A. (2006). Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine, and amphetamine in prison. Addiction, 101, 1125-1132.
52. Taxman, F. S., Perdoni, M., & Harrison, L. D. (2007). Drug treatment services for adult offenders:The state of the state. Journal of Substance Abuse Treatment, 32, 239-254.
53. Tomasino, V., Swanson, A. J., Nolan, J., & Shuman, H. (2001). The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates. Mount Sinai Journal of Medicine, 68, 14-20.
54. Walters, S. T., Ciark, M. D., Gingerich, R., & Meltzer, M. (2007). Motivating offenders to change: A guide for probation & parole officers. Practice Monograph, National Institute of Corrections (NIC) - US Department of Justice. (NIC Accession number 022253).
55. Wish, E. D., Hoffman, J. A., & Nemes, S. (1997). The validity of self-reports at treatment admission and follow-up. In Harrison L., & Hughes A. (Eds.), The validity of self-reported drug use: Improving the accuracy of survey estimates (pp. 227-246). Rockville, MD: National Institute on Drug Abuse.